[Chemotherapy for biliary tract cancers: general remarks].
Funakoshi
Akihiro
A
Department of Gastroenterology, National Kyushu Cancer Center.
Sumii
Toshihiko
T
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001661:Biliary Tract Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003561:Cytarabine; D003841:Deoxycytidine / Q000031:analogs & derivatives; D004317:Doxorubicin; D004358:Drug Therapy / Q000592:standards; D006801:Humans; D005641:Tegafur; D016896:Treatment Outcome; D000093542:Gemcitabine
D000970:Antineoplastic Agents; D003561:Cytarabine; D003841:Deoxycytidine; D005641:Tegafur; D004317:Doxorubicin; D000093542:Gemcitabine